as 12-17-2024 4:00pm EST
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Founded: | 1932 | Country: | United States |
Employees: | N/A | City: | MELVILLE |
Market Cap: | 8.9B | IPO Year: | 1995 |
Target Price: | $78.89 | AVG Volume (30 days): | 1.8M |
Analyst Decision: | Buy | Number of Analysts: | 9 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.42 | EPS Growth: | -27.71 |
52 Week Low/High: | $63.67 - $82.63 | Next Earning Date: | 11-05-2024 |
Revenue: | $12,499,000,000 | Revenue Growth: | -1.53% |
Revenue Growth (this year): | 6.26% | Revenue Growth (next year): | 3.85% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Ettinger Michael S | HSIC | EVP & Chief Operating Officer | Nov 18 '24 | Sell | $75.00 | 12,240 | $918,000.00 | 87,706 |
HSIC Breaking Stock News: Dive into HSIC Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Zacks
5 days ago
Benzinga
6 days ago
Argus Research
7 days ago
Zacks
13 days ago
MT Newswires
14 days ago
Argus Research
14 days ago
Argus Research
21 days ago
The information presented on this page, "HSIC Henry Schein Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.